BioCentury | Mar 17, 2021
Deals

March 17 Quick Takes: Merck-Amathus enter neurodegenerative disease collaboration; plus WuXi, Sana-Fujifilm, Rubius, Inflammatix, StrideBio and more

...of XVR011 to treat COVID-19. VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures, SRIW, Noshaq, Vives IUF, SambrInvest...
BioCentury | Jan 23, 2020
Financial News

Jan. 22 Financial Quick Takes: Genmab-J&J, Adaptimmune, Revolution, PDC*line

...backed by new investors Korean Investment Partners, Shinhan-Cognitive Start-up Fund, UTC 2019 Bioventurefund, SRIW and Sambrinvest...
BioCentury | May 17, 2019
Financial News

Tools4Patient raises €4M to refine, expand placebo response analytics

...from institutional investors for the first time, CEO Dominique Demolle told BioCentury. Innovation Fund and Sambrinvest...
BioCentury | Oct 5, 2018
Financial News

Minoryx raises €21M series B, advances MIN-102

...million) on Sept. 26 in a series B round led by Fund+. SFPI, S.R.I.W. and Sambrinvest...
BioCentury | Oct 26, 2016
Financial News

Fund+ closes EUR 125M fund

...exceeding its EUR 100 million ($108.9 million) target. Investors included SFPI-FPIM, SRIW, Meusinvest, Spinventure and Sambrinvest...
BioCentury | Sep 5, 2016
Financial News

OncoDNA completes venture financing

...Type: Venture financing Raised: EUR7.7 million ($8.7 million) Investors: Institute of Pathology and Genetics; Invest4OncoDNA; Sambrinvest...
BioCentury | Apr 2, 2012
Financial News

Promethera completes venture financing

...Investors: Boehringer Ingelheim Venture Fund; venture arm of Shire plc ; Mitsui Global Investment; ATMI; Sambrinvest...
BioCentury | Apr 2, 2012
Finance

Celling the liver

...Fund; the venture arm of Shire plc (LSE:SHP; NASDAQ:SHPGY); Mitsui Global Investment; ATMI (NASDAQ:ATMI); and Sambrinvest...
BioCentury | Mar 29, 2012
Financial News

Promethera closes series B

...Fund; the venture arm of Shire plc (LSE:SHP; NASDAQ:SHPGY); Mitsui Global Investment; ATMI (NASDAQ:ATMI); and Sambrinvest...
Items per page:
1 - 9 of 9
BioCentury | Mar 17, 2021
Deals

March 17 Quick Takes: Merck-Amathus enter neurodegenerative disease collaboration; plus WuXi, Sana-Fujifilm, Rubius, Inflammatix, StrideBio and more

...of XVR011 to treat COVID-19. VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures, SRIW, Noshaq, Vives IUF, SambrInvest...
BioCentury | Jan 23, 2020
Financial News

Jan. 22 Financial Quick Takes: Genmab-J&J, Adaptimmune, Revolution, PDC*line

...backed by new investors Korean Investment Partners, Shinhan-Cognitive Start-up Fund, UTC 2019 Bioventurefund, SRIW and Sambrinvest...
BioCentury | May 17, 2019
Financial News

Tools4Patient raises €4M to refine, expand placebo response analytics

...from institutional investors for the first time, CEO Dominique Demolle told BioCentury. Innovation Fund and Sambrinvest...
BioCentury | Oct 5, 2018
Financial News

Minoryx raises €21M series B, advances MIN-102

...million) on Sept. 26 in a series B round led by Fund+. SFPI, S.R.I.W. and Sambrinvest...
BioCentury | Oct 26, 2016
Financial News

Fund+ closes EUR 125M fund

...exceeding its EUR 100 million ($108.9 million) target. Investors included SFPI-FPIM, SRIW, Meusinvest, Spinventure and Sambrinvest...
BioCentury | Sep 5, 2016
Financial News

OncoDNA completes venture financing

...Type: Venture financing Raised: EUR7.7 million ($8.7 million) Investors: Institute of Pathology and Genetics; Invest4OncoDNA; Sambrinvest...
BioCentury | Apr 2, 2012
Financial News

Promethera completes venture financing

...Investors: Boehringer Ingelheim Venture Fund; venture arm of Shire plc ; Mitsui Global Investment; ATMI; Sambrinvest...
BioCentury | Apr 2, 2012
Finance

Celling the liver

...Fund; the venture arm of Shire plc (LSE:SHP; NASDAQ:SHPGY); Mitsui Global Investment; ATMI (NASDAQ:ATMI); and Sambrinvest...
BioCentury | Mar 29, 2012
Financial News

Promethera closes series B

...Fund; the venture arm of Shire plc (LSE:SHP; NASDAQ:SHPGY); Mitsui Global Investment; ATMI (NASDAQ:ATMI); and Sambrinvest...
Items per page:
1 - 9 of 9